Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety of AUT00206 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In LondonThis study evaluates the safety of APN1125 for people with schizophrenia.
Recruitment is currently suspended.
In Long BeachThis study evaluated the safety and effectiveness of PERSERIS for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Garden Grove
The Effect of Salutogenic Approach Based Interview on Sense of Coherence and Psychological Resistance of People With Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In IstanbulSarcosine (N-methylglycine) Trial for Individuals At Risk for Developing Schizophrenia and Related Disorders
This study was withdrawn before enrollment.
In Jerusalem
This study has finished and is no longer accepting participants.
In Odense CThis study evaluated the safety and effectiveness of talnetant for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Scottsdale
Treatment of Negative Symptoms of Schizophrenia With Transcranial Direct Current Stimulation (tDCS): A Randomized, Double-blinded, Sham-controlled, Clinical Trial
This study has finished and is no longer accepting participants.
In São PauloComparative Effectiveness of Social Cognition and Interaction Training Program (SCIT) Versus Training of Affect Recognition Program (TAR) for Outpatients With Schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSeroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
Read the official source — NCT00234377A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching Any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL®) in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including VancouverOpen-label Multicentre Study on Efficacy and Safety of Oral Quetiapine (Seroquel XR) in Adults With Schizophrenia
This study ended early.
Multiple locations, including BangkokResearchers are comparing Sodium Butyrate and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.
This study was withdrawn before enrollment.
In ShanghaiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.